Nursing care
Rho(D) Immune Globulin: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Rho(D) immune globulin is given to an Rh-negative mother carrying or delivering an Rh-positive baby to prevent her immune system from forming anti-D antibodies. Standard timing is around 28 weeks' gestation and again within 72 hours of delivery if the baby is confirmed Rh-positive. It does nothing for a mother who is already sensitised.
Mechanism, simply
Rho(D) immune globulin is passive immunisation. It supplies preformed anti-D antibodies that bind any Rh-positive fetal red cells that have crossed into the mother's circulation, clearing them before her own immune system recognises them as foreign.
If that recognition happens unchecked, the mother forms her own anti-D antibodies and stays sensitised for life. In a future pregnancy with another Rh-positive fetus, those antibodies cross the placenta and destroy fetal red cells, causing haemolytic disease of the newborn. The injection prevents that first sensitising exposure from turning into a permanent immune memory.
It only works before sensitisation has occurred. Once a mother has a positive antibody screen for anti-D, giving Rho(D) immune globulin has no effect — the drug prevents antibody formation, it does not treat it.
Indications you will see on the ward
The two standard doses are antenatal, around 28 weeks' gestation, and postnatal, within 72 hours of delivery, given only if the newborn's blood type confirms Rh-positive. If the baby is Rh-negative, the postnatal dose is not needed.
You will also see it ordered after any event that risks fetomaternal haemorrhage in an Rh-negative woman: amniocentesis, chorionic villus sampling, external cephalic version, abdominal trauma, ectopic pregnancy, miscarriage, or antepartum bleeding. Each of these is a separate indication for dosing, not covered by the 28-week injection alone.
Confirm Rh status and antibody screen before administration in every case. The drug is only indicated for a mother who is Rh-negative and unsensitised — check the chart, don't assume the indication from the clinical scenario alone.
Assessment before administration
Verify maternal blood type and Rh status, and confirm the antibody screen is negative. A positive indirect Coombs test means sensitisation has already occurred, and the injection is not indicated — flag this to the provider rather than administering it.
Check the newborn's cord blood type postnatally before giving the postpartum dose; it is only given when the baby types Rh-positive.
Ask about prior Rho(D) immune globulin doses this pregnancy and any history of allergic reaction to immune globulin products or thimerosal, and confirm consent, since this is a blood product derived from pooled human plasma.
Toxicity and the antidote
There is no antidote to Rho(D) immune globulin, and true toxicity from a correctly dosed injection is rare. Overdose is not a typical clinical concern with standard dosing protocols.
The main safety issue is hypersensitivity: injection site soreness is common and expected, but watch for signs of an anaphylactoid reaction, urticaria, dyspnoea, or hypotension, and be prepared to manage it supportively with epinephrine and airway support if it occurs.
Report and document if a dose is given to a sensitised mother or to an Rh-positive mother in error. It won't cause the fetus harm in that scenario, but it represents a medication error that needs correction in the record and repeat serologic testing to confirm status.
Interactions that matter
Live virus vaccines, MMR and varicella in particular, should be deferred for about three months after Rho(D) immune globulin administration. The antibodies in the product can blunt the immune response to the vaccine, reducing its effectiveness.
If the mother received a live vaccine shortly before the injection was due, note it in the record so the provider can weigh delaying either intervention.
There are no significant drug-drug interactions with routine maternal medications; the concern is specifically with immune response to live vaccines, not pharmacologic interaction.
What the patient must be told
Explain that the injection protects a future pregnancy, not this one. It prevents her body from forming antibodies against Rh-positive blood cells so that a later Rh-positive baby is not put at risk of haemolytic disease.
Tell her the dose given around 28 weeks does not remove the need for a second dose after delivery if the baby is confirmed Rh-positive, and that missing either dose leaves her unprotected for future pregnancies.
Advise her to mention her Rh-negative status and Rho(D) immune globulin history at every future pregnancy booking, and after any bleeding, trauma, or invasive procedure during pregnancy, since each of those may call for an additional dose.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our maternity and newborn practice questions are the closest set to what this page covers.
Common questions
Does Rho(D) immune globulin protect this pregnancy or the next one?
It protects future pregnancies. It prevents the mother from forming anti-D antibodies now, so a later Rh-positive fetus is not attacked by antibodies she made in this pregnancy. It does nothing for a fetus already affected by existing maternal antibodies.
What if the mother is already sensitised before the injection is due?
Rho(D) immune globulin is not given once the antibody screen is positive for anti-D — it cannot undo existing sensitisation. Check the indirect Coombs result before administering; a positive result means the injection is not indicated and the provider needs to know.
Why is the postnatal dose only given after the baby's blood type is known?
The postnatal dose is only needed if the newborn is Rh-positive, since an Rh-negative baby poses no sensitisation risk to the mother. Cord blood typing confirms this before the dose is given, usually within 72 hours of delivery.
Can Rho(D) immune globulin be given alongside the MMR vaccine?
No, live vaccines like MMR and varicella should be spaced about three months apart from Rho(D) immune globulin, since the antibodies can blunt the vaccine's effect. This matters most postpartum, when both may otherwise be considered around the same visit.
What is the most common adverse reaction nurses should watch for?
Injection site soreness is expected and not a concern. Rare but important to watch for are signs of hypersensitivity — urticaria, dyspnoea, or hypotension — which need prompt supportive management.